Peroxisome proliferator-activated receptors as therapeutic targets in inflammation
- PMID: 14642685
- DOI: 10.1016/j.jacc.2003.08.017
Peroxisome proliferator-activated receptors as therapeutic targets in inflammation
Comment on
-
The effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non-diabetic coronary artery disease patients.J Am Coll Cardiol. 2003 Nov 19;42(10):1757-63. doi: 10.1016/j.jacc.2003.04.001. J Am Coll Cardiol. 2003. PMID: 14642684 Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
